カテゴリー： MarketsandMarkets, 世界, 医療/バイオ

軟骨修復/軟骨再生のグローバル市場予測（～2028）：細胞系、非細胞系

◆英語タイトル：Cartilage Repair/Cartilage Regeneration Market by Treatment Modalities (Cell-Based (Chondrocyte Transplantation, Stem Cells, Growth Factors), Non-Cell (Tissue Scaffolds)), Application (Hyaline, Fibrocartilage), Site, and Region - Global Forecast to 2028

MarketsandMarketsが発行した調査報告書（BT4781-24）◆商品コード：BT4781-24
◆発行会社（リサーチ会社）：MarketsandMarkets
◆発行日：2023年12月20日
◆ページ数：155
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後24時間以内）
◆調査対象地域：グローバル
◆産業分野：バイオ
◆販売価格オプション（消費税別）
Single User（1名様閲覧）USD4,950 ⇒換算￥752,400見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算￥1,010,800見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算￥1,238,800見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

“世界の軟骨修復/軟骨再生市場は、2023年の13億米ドルから2028年には28億米ドルに達すると予測され、予測期間中の年平均成長率は17.2％”軟骨細胞移植、成長因子、幹細胞のような細胞ベースの手順は、主に、軟骨修復処置の数の増加、変形性関節症の症例の増加、今後数年間で多くの病院での細胞ベースの研究と進歩を促進すると予想されるによって駆動されます。

“予測期間中、用途別セグメント市場において、ヒアリン軟骨セグメントが最も高い市場シェアを占める”
軟骨修復/軟骨再生市場は、セグメントの用途に基づき、ヒアリン軟骨と線維軟骨に分類されます。ヒアリン軟骨は市場で最も高い成長が見込まれており、その理由として、資金調達が可能であること、研究開発への投資が増加していること、新興国における成長機会の増加がヒアリン軟骨市場を牽引することが挙げられます。

“軟骨修復/軟骨再生市場において、予測期間中、地域別では北米セグメントが最も高い市場シェアを占めつ”
地域別に見ると、軟骨修復/軟骨再生市場は北米、ヨーロッパ、アジア太平洋、その他の地域に分けられます。2022年には、軟骨修復市場の主要プレーヤーが主にアメリカやカナダのような国々で存在感を示し、人工膝関節置換術の件数が増加し、軟骨の損傷や傷害の治療のために軟骨修復製品が使用されていることから、北米が最も高い市場となっています。

供給側一次インタビューの企業タイプ別、呼称別、地域別の内訳は以下の通りです：
- 企業タイプ別 ティア1（30％）、ティア2（44％）、ティア3（26％）
- 役職別 Cレベル(30％)、ディレクターレベル(33％)、その他(37％)
- 地域別 北米 (40％)、ヨーロッパ (28％)、アジア太平洋 (18％)、その他地域(14％)

主な企業は、Smith+Nephew (UK), DePuy Synthes (Johnson & Johnson) (US), Zimmer Biomet Holdings, Inc. (US), Stryker Corporation (US), Vericel Corporation (US), B. Braun Melsungen AG (US), Anika Therapeutics (US), CONMED Corporation (US), MEDIPOST (South Korea), RTI Surgical (US), Arthrex, Inc. (US), Regrow Biosciences (India), Geistlich Pharma AG (Switzerland), AlloSource (US), Orthocell Ltd, (Australia), Matricel GmbH (Germany), CartiHeal, Inc. (Israel), Regentis Biomaterials (Israel), Theracell Advanced Biotechnology (Greece) and LifeNet Health (US)などが含まれます。

調査範囲：
この調査レポートは、軟骨修復/軟骨再生市場に使用される製品、用途、適用部位に分類しています。
軟骨修復/軟骨再生の治療方法は、細胞ベース、すなわち軟骨細胞移植、成長因子、幹細胞と、非細胞ベース、すなわち組織足場、無細胞複合材料に分けられます。応用分野は、ヒアルロン酸軟骨と線維軟骨に分類されます。 適用部位セグメントは膝、股関節、足首＆足、その他の適用部位（鼻、肩）に分類され、地域セグメントは北米、ヨーロッパ、アジア太平洋、その他の地域に分類されます。軟骨修復/軟骨再生市場の成長に影響を与える促進要因、阻害要因、課題、機会などの市場力学のような主要要因に関する詳細情報を網羅しています。
軟骨修復/軟骨再生市場に関連する企業の新発売、開発、合併・買収など、主要な業界プレイヤーの詳細な分析もカバーしています。軟骨修復/軟骨再生市場のエコシステムにおける今後の新興企業の競争分析もカバーしています。

レポート購入の主な利点：
本レポートは、軟骨修復/軟骨再生市場全体およびサブセグメントの収益数の最も近い近似値に関する情報を提供することで、本市場の市場リーダー/新規参入者を支援します。本レポートは、利害関係者が競争状況を理解し、自社の事業をより良く位置づけ、適切な市場参入戦略を計画するためのより多くの洞察を得るのに役立ちます。また、当レポートは、関係者が市場の鼓動を理解するのに役立ち、主要な市場促進要因、阻害要因、課題、機会に関する情報を提供します。

本レポートは、以下のポイントに関する洞察を提供します：
- 主な促進要因（変形性関節症の罹患率の増加、研究資金と投資の増加、スポーツや事故に関連した整形外科的損傷の増加）、抑制要因（軟骨修復手術の高額費用、不利な償還シナリオ）、機会（軟骨修復市場における技術進歩、再生医療分野の発展）、課題（軟骨ベースの幹細胞製品の限界、熟練人材の必要性）の分析が軟骨修復/軟骨再生市場の成長に影響を与えています。
- 製品開発/イノベーション： 軟骨修復/軟骨再生市場における今後の技術、研究開発活動、新製品・新サービスの発売に関する詳細な洞察を記載しています。
- 市場開発： 有利な市場に関する包括的情報 - 当レポートでは、様々な地域における軟骨修復/軟骨再生市場を分析しています。
- 市場の多様化： 軟骨修復/軟骨再生市場における新製品とサービス、未開拓の地域、最近の開発、投資に関する詳細な情報を提供します。
- 競争力の評価： 軟骨修復/軟骨再生市場戦略における主要企業などの市場シェア、成長戦略、サービス提供などを詳細に評価しています。

1.　イントロダクション
2.　調査方法
3.　エグゼクティブサマリー
4.　プレミアムインサイト
5.　市場概要
6.　世界の軟骨修復/軟骨再生市場規模：治療手段別
7.　世界の軟骨修復/軟骨再生市場規模：部位別
8.　世界の軟骨修復/軟骨再生市場規模：用途別
9.　世界の軟骨修復/軟骨再生市場規模：地域別
10.　競争環境
11.　企業情報
12.　付録

❖ レポートの目次 ❖

1 INTRODUCTION 23
1.1 STUDY OBJECTIVES 23
1.2 MARKET DEFINITION 23
TABLE 1 INCLUSIONS AND EXCLUSIONS 23
1.3 MARKET SCOPE 24
1.3.1 MARKETS COVERED 24
1.3.2 YEARS CONSIDERED 24
1.3.3 CURRENCY CONSIDERED 25
1.4 STAKEHOLDERS 25
1.5 SUMMARY OF CHANGES 25
1.5.1 RECESSION IMPACT 25
2 RESEARCH METHODOLOGY 26
2.1 RESEARCH DATA 26
FIGURE 1 CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET: RESEARCH DESIGN 26
2.1.1 SECONDARY DATA 27
2.1.1.1 Secondary sources 27
2.1.2 PRIMARY DATA 28
FIGURE 2 PRIMARY SOURCES 28
2.1.2.1 Key data from primary sources 29
2.1.2.2 Key industry insights 30
2.1.2.3 Breakdown of primary interviews 30
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 30
2.2 MARKET SIZE ESTIMATION 31
2.2.1 APPROACH 1: COMPANY REVENUE ESTIMATION APPROACH 31
FIGURE 4 BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION 31
2.2.2 APPROACH 2: CALCULATING MARKET SIZE FROM NUMBER OF CARTILAGE REPAIR TREATMENT PROCEDURES 32
TABLE 2 REVENUE ESTIMATION APPROACH BY CALCULATING NUMBER OF CARTILAGE REPAIR TREATMENTS PROCEDURES IN US 32
2.2.3 APPROACH 3: CORPORATE PRESENTATIONS OF COMPANIES AND PRIMARY INTERVIEWS 32
2.2.4 APPROACH 4: PRIMARY INTERVIEWS 32
2.2.5 APPROACH 5: FINAL MARKET CALCULATION 33
FIGURE 5 GROWTH FORECAST 33
FIGURE 6 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 33
FIGURE 7 TOP-DOWN APPROACH 34
 
2.3 MARKET BREAKDOWN & DATA TRIANGULATION 34
FIGURE 8 DATA TRIANGULATION METHODOLOGY 35
2.4 MARKET SHARE ANALYSIS 36
2.5 MARKET ASSUMPTIONS 36
2.6 RISK ASSESSMENT 36
2.7 LIMITATIONS 37
2.8 CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET: RECESSION IMPACT ANALYSIS 37
3 EXECUTIVE SUMMARY 38
FIGURE 9 CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2023 VS. 2028 (USD MILLION) 38
FIGURE 10 CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION) 39
FIGURE 11 CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY APPLICATION SITE, 2023 VS. 2028 (USD MILLION) 39
FIGURE 12 CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET: GEOGRAPHIC SNAPSHOT 40
4 PREMIUM INSIGHTS 41
4.1 CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET OVERVIEW 41
FIGURE 13 INCREASING INCIDENCE OF OSTEOARTHRITIS TO DRIVE MARKET 41
4.2 NORTH AMERICA: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY APPLICATION AND COUNTRY, 2022 42
FIGURE 14 HYALINE CARTILAGE HELD LARGEST SHARE IN 2022 42
4.3 CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 42
FIGURE 15 JAPAN TO WITNESS HIGHEST GROWTH DURING FORECAST PERIOD 42
5 MARKET OVERVIEW 43
5.1 INTRODUCTION 43
5.2 MARKET DYNAMICS 43
FIGURE 16 CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 43
5.2.1 MARKET DRIVERS 44
5.2.1.1 Increasing incidence of osteoarthritis 44
5.2.1.2 Increasing research funding and investments 44
5.2.1.3 Rising number of sports and accident-related orthopedic injuries 45
5.2.2 RESTRAINTS 45
5.2.2.1 High cost of cartilage repair surgeries 45
5.2.2.2 Unfavorable reimbursement scenario 45
5.2.3 OPPORTUNITIES 46
5.2.3.1 Technological advancements 46
5.2.3.2 Developments in regenerative medicine 46
5.2.4 CHALLENGES 47
5.2.4.1 Limitations of cartilage-based stem cell products 47
5.2.4.2 Need for skilled personnel 47
5.3 SUPPLY CHAIN ANALYSIS 48
FIGURE 17 DISTRIBUTION—KEY STRATEGY PREFERRED BY PROMINENT COMPANIES 48
5.4 REGULATORY LANDSCAPE 49
5.4.1 INTRODUCTION 49
5.4.2 NORTH AMERICA 49
TABLE 3 CLASSIFICATION BASED ON SUBMISSION REQUIRED FOR REGULATORY APPROVAL 49
5.4.3 EUROPE 50
5.4.4 ASIA PACIFIC 50
5.5 PATENT ANALYSIS 52
FIGURE 18 PATENT ANALYSIS FOR CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET 52
5.6 PIPELINE ANALYSIS 53
5.6.1 PIPELINE ANALYSIS, BY CLINICAL TRIAL PHASE 53
FIGURE 19 CARTILAGE REPAIR CANDIDATE PRODUCTS IN CLINICAL PHASES ONE TO FOUR 53
TABLE 4 INDICATIVE LIST OF CANDIDATES IN CLINICAL TRIALS 53
5.7 TECHNOLOGY ANALYSIS 54
6 CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY 55
6.1 INTRODUCTION 56
TABLE 5 CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2021–2028 (USD MILLION) 56
6.2 CELL-BASED CARTILAGE REPAIR/CARTILAGE REGENERATION 56
TABLE 6 CELL-BASED CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 56
TABLE 7 CELL-BASED CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY REGION, 2021–2028 (USD MILLION) 57
TABLE 8 NORTH AMERICA: CELL-BASED CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 57
TABLE 9 EUROPE: CELL-BASED CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 57
TABLE 10 ASIA PACIFIC: CELL-BASED CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 58
6.2.1 CHONDROCYTE TRANSPLANTATION 58
6.2.1.1 Cost-effectiveness to support market growth 58
TABLE 11 CHONDROCYTE TRANSPLANTATION MARKET, BY REGION, 2021–2028 (USD MILLION) 59
TABLE 12 NORTH AMERICA: CHONDROCYTE TRANSPLANTATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 59
6.2.2 GROWTH FACTORS 59
6.2.2.1 Promising results associated with growth factors to drive market 59
TABLE 13 GROWTH FACTORS MARKET, BY REGION, 2021–2028 (USD MILLION) 59
TABLE 14 NORTH AMERICA: GROWTH FACTORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 60
6.2.3 STEM CELLS 60
6.2.3.1 Advancements in stem cell-based tissue engineering to support market growth 60
TABLE 15 STEM CELLS MARKET, BY REGION, 2021–2028 (USD MILLION) 60
TABLE 16 NORTH AMERICA: STEM CELLS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 61
6.3 NON-CELL-BASED CARTILAGE REPAIR/CARTILAGE REGENERATION 61
TABLE 17 NON-CELL-BASED CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 61
TABLE 18 NON-CELL-BASED CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY REGION, 2021–2028 (USD MILLION) 61
TABLE 19 NORTH AMERICA: NON-CELL-BASED CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 62
TABLE 20 EUROPE: NON-CELL-BASED CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 62
TABLE 21 ASIA PACIFIC: NON-CELL-BASED CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 62
6.3.1 TISSUE SCAFFOLDS 63
6.3.1.1 Benefits of one-step procedure likely to boost market growth 63
TABLE 22 TISSUE SCAFFOLDS MARKET, BY REGION, 2021–2028 (USD MILLION) 63
6.3.2 CELL-FREE COMPOSITES 63
6.3.2.1 Increasing research to support market growth 63
TABLE 23 CELL-FREE COMPOSITES MARKET, BY REGION, 2021–2028 (USD MILLION) 64
7 CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET,
BY APPLICATION SITE 65
7.1 INTRODUCTION 66
TABLE 24 CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY APPLICATION SITE, 2021–2028 (USD MILLION) 66
7.2 KNEE 66
7.2.1 INCREASING CASES OF KNEE ARTHROSCOPY TO DRIVE MARKET GROWTH 66
TABLE 25 KNEE CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY REGION, 2021–2028 (USD MILLION) 67
TABLE 26 NORTH AMERICA: KNEE CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 67
TABLE 27 EUROPE: KNEE CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 67
TABLE 28 ASIA PACIFIC: KNEE CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 68
7.3 HIP 68
7.3.1 INCREASING ADOPTION OF MINIMALLY INVASIVE ARTHROSCOPY PROCEDURES TO SUPPORT MARKET GROWTH 68
TABLE 29 HIP CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY REGION, 2021–2028 (USD MILLION) 68
TABLE 30 NORTH AMERICA: HIP CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 69
TABLE 31 EUROPE: HIP CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 69
TABLE 32 ASIA PACIFIC: HIP CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 69
7.4 ANKLE & FOOT 70
7.4.1 INCREASING SPORTS INJURIES TO DRIVE DEMAND 70
TABLE 33 ANKLE & FOOT CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY REGION, 2021–2028 (USD MILLION) 70
TABLE 34 NORTH AMERICA: ANKLE & FOOT CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 70
TABLE 35 EUROPE: ANKLE & FOOT CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 71
7.5 OTHER APPLICATION SITES 71
TABLE 36 CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET FOR OTHER APPLICATION SITES, BY REGION, 2021–2028 (USD MILLION) 71
TABLE 37 NORTH AMERICA: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET FOR OTHER APPLICATION SITES, BY COUNTRY, 2021–2028 (USD MILLION) 72
8 CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY APPLICATION 73
8.1 INTRODUCTION 74
TABLE 38 CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 74
8.2 HYALINE CARTILAGE 74
8.2.1 HYALINE CARTILAGE SEGMENT TO HOLD LARGER MARKET SHARE 74
TABLE 39 HYALINE CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY REGION, 2021–2028 (USD MILLION) 75
TABLE 40 NORTH AMERICA: HYALINE CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 75
TABLE 41 EUROPE: HYALINE CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 75
TABLE 42 ASIA PACIFIC: HYALINE CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 76
8.3 FIBROCARTILAGE 76
8.3.1 SUPPORT AND STRENGTH ADVANTAGES FOR SURROUNDING STRUCTURES TO DRIVE MARKET 76
TABLE 43 FIBROCARTILAGE REPAIR/REGENERATION MARKET, BY REGION, 2021–2028 (USD MILLION) 76
TABLE 44 NORTH AMERICA: FIBROCARTILAGE REPAIR/REGENERATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 77
TABLE 45 EUROPE: FIBROCARTILAGE REPAIR/REGENERATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 77
TABLE 46 ASIA PACIFIC: FIBROCARTILAGE REPAIR/REGENERATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 77
9 CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY REGION 78
9.1 INTRODUCTION 79
TABLE 47 CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY REGION, 2021–2028 (USD MILLION) 79
9.2 NORTH AMERICA 79
9.2.1 NORTH AMERICA: RECESSION IMPACT 79
FIGURE 20 NORTH AMERICA: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SNAPSHOT 80
TABLE 48 NORTH AMERICA: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 81
TABLE 49 NORTH AMERICA: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2021–2028 (USD MILLION) 81
TABLE 50 NORTH AMERICA: CELL-BASED CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 81
TABLE 51 NORTH AMERICA: NON-CELL-BASED CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 82
TABLE 52 NORTH AMERICA: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 82
TABLE 53 NORTH AMERICA: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY APPLICATION SITE, 2021–2028 (USD MILLION) 82
9.2.2 US 83
9.2.2.1 Increasing incidence of osteoporosis to drive market 83
TABLE 54 US: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2021–2028 (USD MILLION) 83
TABLE 55 US: CELL-BASED CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 83
TABLE 56 US: NON-CELL-BASED CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 84
TABLE 57 US: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 84
TABLE 58 US: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY APPLICATION SITE, 2021–2028 (USD MILLION) 84
9.2.3 CANADA 85
9.2.3.1 Increasing investments in regenerative medicine research to drive market 85
TABLE 59 CANADA: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2021–2028 (USD MILLION) 85
TABLE 60 CANADA: CELL-BASED CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 85
TABLE 61 CANADA: NON-CELL-BASED CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 86
TABLE 62 CANADA: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 86
TABLE 63 CANADA: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY APPLICATION SITE, 2021–2028 (USD MILLION) 86
 
9.3 EUROPE 87
9.3.1 EUROPE: RECESSION IMPACT 87
TABLE 64 EUROPE: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 87
TABLE 65 EUROPE: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2021–2028 (USD MILLION) 88
TABLE 66 EUROPE: CELL-BASED CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 88
TABLE 67 EUROPE: NON-CELL-BASED CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 88
TABLE 68 EUROPE: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 89
TABLE 69 EUROPE: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY APPLICATION SITE, 2021–2028 (USD MILLION) 89
9.3.2 GERMANY 89
9.3.2.1 Strong R&D base and focus on minimally invasive surgeries to support market growth 89
TABLE 70 GERMANY: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2021–2028 (USD MILLION) 90
TABLE 71 GERMANY: CELL-BASED CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 90
TABLE 72 GERMANY: NON-CELL-BASED CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 90
TABLE 73 GERMANY: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 91
TABLE 74 GERMANY: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY APPLICATION SITE, 2021–2028 (USD MILLION) 91
9.3.3 UK 91
9.3.3.1 Rising prevalence of joint diseases to boost demand 91
TABLE 75 UK: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2021–2028 (USD MILLION) 92
TABLE 76 UK: CELL-BASED CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 92
TABLE 77 UK: NON-CELL-BASED CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 92
TABLE 78 UK: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 93
TABLE 79 UK: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY APPLICATION SITE, 2021–2028 (USD MILLION) 93
9.3.4 FRANCE 93
9.3.4.1 Rising degenerative disease and healthcare expenditure to drive market 93
TABLE 80 FRANCE: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2021–2028 (USD MILLION) 94
TABLE 81 FRANCE: CELL-BASED CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 94
TABLE 82 FRANCE: NON-CELL-BASED CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 94
TABLE 83 FRANCE: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 95
TABLE 84 FRANCE: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY APPLICATION SITE, 2021–2028 (USD MILLION) 95
9.3.5 REST OF EUROPE 95
TABLE 85 REST OF EUROPE: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2021–2028 (USD MILLION) 96
TABLE 86 REST OF EUROPE: CELL-BASED CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 96
TABLE 87 REST OF EUROPE: NON-CELL-BASED CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 96
TABLE 88 REST OF EUROPE: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 97
TABLE 89 REST OF EUROPE: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY APPLICATION SITE, 2021–2028 (USD MILLION) 97
9.4 ASIA PACIFIC 97
9.4.1 ASIA PACIFIC: RECESSION IMPACT 97
FIGURE 21 ASIA PACIFIC: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET 98
TABLE 90 ASIA PACIFIC: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 99
TABLE 91 ASIA PACIFIC: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2021–2028 (USD MILLION) 99
TABLE 92 ASIA PACIFIC: CELL-BASED CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 99
TABLE 93 ASIA PACIFIC: NON-CELL-BASED CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 100
TABLE 94 ASIA PACIFIC: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 100
TABLE 95 ASIA PACIFIC: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY APPLICATION SITE, 2021–2028 (USD MILLION) 100
9.4.2 JAPAN 101
9.4.2.1 Japan to hold largest market share throughout forecast period 101
TABLE 96 JAPAN: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2021–2028 (USD MILLION) 101
TABLE 97 JAPAN: CELL-BASED CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 101
TABLE 98 JAPAN: NON-CELL-BASED CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 102
TABLE 99 JAPAN: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 102
TABLE 100 JAPAN: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY APPLICATION SITE, 2021–2028 (USD MILLION) 102
9.4.3 CHINA 103
9.4.3.1 China to register highest growth in APAC market 103
TABLE 101 CHINA: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2021–2028 (USD MILLION) 103
TABLE 102 CHINA: CELL-BASED CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 103
TABLE 103 CHINA: NON-CELL-BASED CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 104
TABLE 104 CHINA: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 104
TABLE 105 CHINA: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY APPLICATION SITE, 2021–2028 (USD MILLION) 104
9.4.4 INDIA 105
9.4.4.1 Rising number of hospitals and developing healthcare infrastructure to propel market growth 105
TABLE 106 INDIA: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2021–2028 (USD MILLION) 105
TABLE 107 INDIA: CELL-BASED CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 105
TABLE 108 INDIA: NON-CELL-BASED CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 106
TABLE 109 INDIA: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 106
TABLE 110 INDIA: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY APPLICATION SITE, 2021–2028 (USD MILLION) 106
9.4.5 REST OF ASIA PACIFIC 107
TABLE 111 REST OF ASIA PACIFIC: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2021–2028 (USD MILLION) 107
TABLE 112 REST OF ASIA PACIFIC: CELL-BASED CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 107
TABLE 113 REST OF ASIA PACIFIC: NON-CELL-BASED CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 108
TABLE 114 REST OF ASIA PACIFIC: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 108
TABLE 115 REST OF ASIA PACIFIC: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY APPLICATION SITE, 2021–2028 (USD MILLION) 108
9.5 REST OF THE WORLD 109
9.5.1 REST OF THE WORLD: RECESSION IMPACT 109
TABLE 116 REST OF THE WORLD: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2021–2028 (USD MILLION) 110
TABLE 117 REST OF THE WORLD: CELL-BASED CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 110
TABLE 118 REST OF THE WORLD: NON-CELL-BASED CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 110
TABLE 119 REST OF THE WORLD: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 111
TABLE 120 REST OF THE WORLD: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY APPLICATION SITE, 2021–2028 (USD MILLION) 111
 
10 COMPETITIVE LANDSCAPE 112
10.1 INTRODUCTION 112
10.2 REVENUE ANALYSIS 112
FIGURE 22 TOP FIVE PLAYERS HAVE DOMINATED MARKET IN LAST FIVE YEARS 112
10.3 MARKET SHARE ANALYSIS 113
FIGURE 23 CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET: MARKET SHARE ANALYSIS, 2022 113
TABLE 121 CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET: DEGREE OF COMPETITION 113
10.4 COMPANY EVALUATION MATRIX 114
10.4.1 STARS 115
10.4.2 EMERGING LEADERS 115
10.4.3 PERVASIVE PLAYERS 115
10.4.4 PARTICIPANTS 115
FIGURE 24 GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET: COMPANY EVALUATION MATRIX, 2022 116
10.5 COMPETITIVE SCENARIO 117
10.5.1 PRODUCT APPROVALS 117
TABLE 122 KEY PRODUCT APPROVALS, JANUARY 2020–NOVEMBER 2023 117
10.5.2 DEALS 117
TABLE 123 KEY DEALS, JANUARY 2020–NOVEMBER 2023 117
10.5.3 OTHER DEVELOPMENTS 118
TABLE 124 OTHER KEY DEVELOPMENTS, JANUARY 2020–NOVEMBER 2023 118
11 COMPANY PROFILES 119
11.1 KEY COMPANIES 119
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
11.1.1 SMITH+NEPHEW 119
TABLE 125 SMITH+NEPHEW: COMPANY OVERVIEW 119
FIGURE 25 SMITH+NEPHEW: COMPANY SNAPSHOT (2022) 120
11.1.2 DEPUY SYNTHES (JOHNSON & JOHNSON) 123
TABLE 126 JOHNSON & JOHNSON: COMPANY OVERVIEW 123
FIGURE 26 JOHNSON & JOHNSON: COMPANY SNAPSHOT (2022) 124
11.1.3 ZIMMER BIOMET HOLDINGS, INC. 127
TABLE 127 ZIMMER BIOMET HOLDINGS, INC.: COMPANY OVERVIEW 127
FIGURE 27 ZIMMER BIOMET HOLDINGS, INC.: COMPANY SNAPSHOT (2022) 128
11.1.4 STRYKER CORPORATION 131
TABLE 128 STRYKER CORPORATION: COMPANY OVERVIEW 131
FIGURE 28 STRYKER CORPORATION: COMPANY SNAPSHOT (2022) 132
11.1.5 VERICEL CORPORATION 134
TABLE 129 VERICEL CORPORATION: COMPANY OVERVIEW 134
FIGURE 29 VERICEL CORPORATION: COMPANY SNAPSHOT (2022) 134
11.1.6 B. BRAUN MELSUNGEN AG 136
TABLE 130 B. BRAUN MELSUNGEN AG: COMPANY OVERVIEW 136
FIGURE 30 B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT (2022) 137
11.1.7 ANIKA THERAPEUTICS, INC. 138
TABLE 131 ANIKA THERAPEUTICS, INC.: COMPANY OVERVIEW 138
FIGURE 31 ANIKA THERAPEUTICS, INC: COMPANY SNAPSHOT (2022) 139
11.1.8 RTI SURGICAL 140
TABLE 132 RTI SURGICAL: COMPANY OVERVIEW 140
11.1.9 CONMED CORPORATION 142
TABLE 133 CONMED CORPORATION.: COMPANY OVERVIEW 142
FIGURE 32 CONMED CORPORATION: COMPANY SNAPSHOT (2022) 143
11.1.10 ARTHREX INC. 145
TABLE 134 ARTHREX INC.: COMPANY OVERVIEW 145
11.1.11 REGROW BIOSCIENCES 146
TABLE 135 REGROW BIOSCIENCES: COMPANY OVERVIEW 146
11.1.12 MEDIPOST 147
TABLE 136 MEDIPOST: COMPANY OVERVIEW 147
FIGURE 33 MEDIPOST: COMPANY SNAPSHOT (2022) 147
11.2 OTHER PLAYERS 150
11.2.1 GEISTLICH PHARMA AG 150
11.2.2 ALLOSOURCE 150
11.2.3 ORTHOCELL LTD. 151
11.2.4 CARTIHEAL, INC. 151
11.2.5 REGENTIS BIOMATERIALS 152
11.2.6 LIFENET HEALTH 152
11.2.7 MATRICEL GMBH 153
11.2.8 THERACELL ADVANCED BIOTECHNOLOGY 153
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
12 APPENDIX 154
12.1 DISCUSSION GUIDE 154
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 157
12.3 CUSTOMIZATION OPTIONS 159
12.4 RELATED REPORTS 159
12.5 AUTHOR DETAILS 160



❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 軟骨修復/軟骨再生のグローバル市場予測（～2028）：細胞系、非細胞系(Cartilage Repair/Cartilage Regeneration Market by Treatment Modalities (Cell-Based (Chondrocyte Transplantation, Stem Cells, Growth Factors), Non-Cell (Tissue Scaffolds)), Application (Hyaline, Fibrocartilage), Site, and Region - Global Forecast to 2028)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • 世界の軟骨修復市場2023-2030：モダリティ別（細胞ベース、非細胞ベース）、用途別（ヒアリン軟骨、線維軟骨）、地域別

    • ◆H&Iグローバルリサーチのお客様（例）◆